Business Context and Reporting Period
Company: Becton, Dickinson and Company (BD)
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2008
Reporting Period: Fiscal quarter ended March 31, 2008
This filing announces the issuance of a press release containing financial results for the first quarter of fiscal year 2008. The report focuses on the methodology used to present non-GAAP financial measures to better reflect underlying operational performance.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity for the reported period. Instead, it details the adjustments management applies to GAAP figures to derive non-GAAP metrics:
- Revenues: Presented at constant foreign exchange rates to remove the impact of currency fluctuations.
- Operating Income: Adjusted to exclude the in-process research and development (R&D) charge from the TriPath Imaging, Inc. acquisition for comparative periods.
- Effective Tax Rate: Adjusted to exclude the non-tax-deductible impact of the TriPath in-process R&D charge.
- Income from Continuing Operations: Adjusted to exclude the TriPath in-process R&D charge.
- Earnings Per Share (EPS): Adjusted to exclude in-process R&D charges from the TriPath acquisition (for the first six months of 2007) and the Plasso Technology, Ltd. acquisition (for the full 2007 fiscal year).
Material Changes and Unusual Items
The filing highlights specific non-recurring items that impacted historical financial reporting and are excluded from management's non-GAAP analysis:
- TriPath Imaging Acquisition: An in-process R&D charge affected reported operating income, effective tax rate, income from continuing operations, and EPS for the first six months of fiscal year 2007.
- Plasso Technology Acquisition: An in-process R&D charge affected reported EPS for the full fiscal year 2007.
- Foreign Exchange: Fluctuations in foreign currency exchange rates are excluded from revenue growth calculations to facilitate period-to-period comparisons.
Guidance, Outlook, and Management Commentary
Management utilizes these non-GAAP measures for internal evaluation, budget planning, and to provide investors with insight into underlying performance. The filing explicitly states that:
- Non-GAAP results are not a substitute for GAAP results and should not be considered in isolation.
- Items excluded from non-GAAP measures may have a material impact on GAAP net income, EPS, or cash flows.
- Management typically uses non-GAAP results in conjunction with GAAP results to address limitations.
The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard disclosures regarding the limitations of non-GAAP measures.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for the actual numerical financial results for the quarter ended March 31, 2008.
- Verify the reconciliation between GAAP and non-GAAP figures to understand the magnitude of the excluded R&D charges.
- Assess the impact of foreign exchange rate fluctuations on reported revenue growth versus constant currency growth.
- Confirm the specific amounts of the in-process R&D charges related to TriPath Imaging and Plasso Technology in the full annual report.